Ecovyst, a provider of advanced materials, specialty catalysts, sulfuric acid and regeneration services, and ChiralVision, a developer of biocatalysis-based technologies...
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding...
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing...
Germany-headquartered Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of...
Eurocolour, the European umbrella organization for manufacturers of pigments, dyes, fillers, and ceramic decoration products, welcomes four new members to its...
Takeda has appointed Julie Kim, currently president of the company’s US business unit, to succeed Christophe Weber as CEO in June 2026, who will retire after 12 years in...
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.
Sage Therapeutics announced that its board of directors has unanimously rejected the proposal it received from Biogen on Jan. 10, 2025, to acquire all outstanding shares...
